Only two infants acquired HIV ( both in the lopinavir/ritonavir arm ) , and HIV-free infant survival was similar between study arms : 92.9 % ( lopinavir/ritonavir ) versus 97.2 % ( efavirenz ) ( P = 0.10 ) .